David M. Hyams

2.7k total citations · 1 hit paper
36 papers, 2.1k citations indexed

About

David M. Hyams is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, David M. Hyams has authored 36 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 9 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in David M. Hyams's work include HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and CAR-T cell therapy research (4 papers). David M. Hyams is often cited by papers focused on HER2/EGFR in Cancer Research (6 papers), Breast Cancer Treatment Studies (5 papers) and CAR-T cell therapy research (4 papers). David M. Hyams collaborates with scholars based in United States, Brazil and Peru. David M. Hyams's co-authors include Norman Wolmark, Bernard Fisher, John Bryant, Marc E. Lippman, D. Lawrence Wickerham, Elizabeth Tan-Chiu, Soonmyung Paik, Chanheun Park, Henry Gómez and Michele Guida and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

David M. Hyams

35 papers receiving 2.0k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

erbB-2 and Response to Doxorubicin in Patients With Axillary Lymph Node-Positive, Hormone Receptor- Negative Breast Cancer

1998 515 citations John Bryant, Bernard Fisher et al. JNCI Journal of the National Cancer Institute profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David M. Hyams United States	19	1.5k	530	429	398	389	36	2.1k
Allan Topham United States	17	1.2k 0.8×	330 0.6×	700 1.6×	319 0.8×	391 1.0×	24	2.6k
Ian Kennedy United States	14	1.7k 1.1×	392 0.7×	279 0.7×	629 1.6×	379 1.0×	21	2.2k
James Pettay United States	25	895 0.6×	305 0.6×	700 1.6×	513 1.3×	210 0.5×	43	1.8k
Jörg Nährig Germany	27	650 0.4×	363 0.7×	636 1.5×	565 1.4×	444 1.1×	51	2.1k
Romano Colombari Italy	27	1.0k 0.7×	508 1.0×	395 0.9×	168 0.4×	123 0.3×	62	2.4k
John L. Hungerford United Kingdom	34	1.3k 0.9×	416 0.8×	787 1.8×	808 2.0×	116 0.3×	121	3.7k
Holger Moch Switzerland	23	830 0.5×	592 1.1×	924 2.2×	301 0.8×	478 1.2×	48	2.2k
Erminia Manfrin Italy	30	1.4k 0.9×	497 0.9×	578 1.3×	237 0.6×	466 1.2×	99	2.4k
Hee Eun Lee South Korea	29	1.3k 0.9×	418 0.8×	1.0k 2.4×	453 1.1×	680 1.7×	86	2.7k
Andreas H. Marx Germany	26	1.3k 0.8×	583 1.1×	698 1.6×	259 0.7×	301 0.8×	75	2.2k

Countries citing papers authored by David M. Hyams

Since Specialization

Citations

This map shows the geographic impact of David M. Hyams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Hyams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Hyams more than expected).

Fields of papers citing papers by David M. Hyams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Hyams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Hyams. The network helps show where David M. Hyams may publish in the future.

Co-authorship network of co-authors of David M. Hyams

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Hyams. A scholar is included among the top collaborators of David M. Hyams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Hyams. David M. Hyams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zager, Jonathan S. & David M. Hyams. (2023). Management of melanoma: can we use gene expression profiling to help guide treatment and surveillance?. Clinical & Experimental Metastasis. 41(4). 439–445. 1 indexed citations

Dasanu, Constantin A, Michael Del Rosario, Ion Codreanu, et al.. (2019). Merkel cell carcinoma: long-term follow-up of a single institution series and clinical outcomes by immunological status. Dermatology Online Journal. 25(2). 2 indexed citations

Markopoulos, Christos, David M. Hyams, Henry Gómez, et al.. (2019). Multigene assays in early breast cancer: Insights from recent phase 3 studies. European Journal of Surgical Oncology. 46(4). 656–666. 20 indexed citations

Hyams, David M., Robert W. Cook, & Antônio C. Buzaid. (2018). Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers. Journal of Surgical Oncology. 119(2). 175–186. 31 indexed citations

Hyams, David M., Eric R. Schuur, Enrique Bargalló‐Rocha, et al.. (2017). Selecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays. Journal of Surgical Oncology. 115(6). 647–662. 10 indexed citations

Hyams, David M., Arlene Chan, Raymond Snyder, et al.. (2013). Cediranib in combination with fulvestrant in hormone-sensitive metastatic breast cancer: a randomized Phase II study. Investigational New Drugs. 31(5). 1345–1354. 33 indexed citations

Smith, C.A., Alessio Pollice, Ling Gu, et al.. (2000). Correlations among p53, Her-2/neu, and ras overexpression and aneuploidy by multiparameter flow cytometry in human breast cancer: evidence for a common phenotypic evolutionary pattern in infiltrating ductal carcinomas.. PubMed. 6(1). 112–26. 41 indexed citations

Wolmark, Norman, Roger P. Smith, Bernard Fisher, et al.. (1998). Adjuvant 5-Fluorouracil and Leucovorin With or Without Interferon Alfa-2a in Colon Carcinoma: National Surgical Adjuvant Breast and Bowel Project Protocol C-05. JNCI Journal of the National Cancer Institute. 90(23). 1810–1816. 78 indexed citations

Hyams, David M., Eleftherios P. Mamounas, Nicholas J. Petrelli, et al.. (1997). A clinical trial to evaluate the worth of preoperative multimodality therapy in patients with operable carcinoma of the rectum. Diseases of the Colon & Rectum. 40(2). 131–139. 286 indexed citations

10.

Rhodes, Judith C., et al.. (1996). Expression of a Putative Immunosuppressive Protein in Human Tumors and Tissues. Pathobiology. 64(5). 233–238. 5 indexed citations

11.

Noffsinger, Amy, David M. Hyams, & Cecilia M. Fenoglio‐Preiser. (1995). Esophageal heterotopic pancreas presenting as an inflammatory mass. Digestive Diseases and Sciences. 40(11). 2373–2379. 15 indexed citations

12.

Miller, Mary Ann, Claire Mazewski, Lawrence M. White, et al.. (1991). Simultaneous immunohistochemical detection of IUdR and BrdU infused intravenously to cancer patients.. Journal of Histochemistry & Cytochemistry. 39(4). 407–412. 27 indexed citations

13.

López-Jamar, José Miguel Esteban, et al.. (1990). Radioimmunotherapy of human colon carcinomatosis xenograft with 90Y-ZCE025 monoclonal antibody: toxicity and tumor phenotype studies.. PubMed. 50(3 Suppl). 989s–992s. 24 indexed citations

14.

Beatty, J. David, David M. Hyams, Barbara Beatty, et al.. (1989). Impact of radiolabeled antibody imaging on management of colon cancer. The American Journal of Surgery. 157(1). 13–19. 30 indexed citations

15.

Hyams, David M.. (1989). Prolongation of Survival of Nude Mice Bearing Human Colon Cancer. Archives of Surgery. 124(2). 175–175. 12 indexed citations

16.

Wagman, Lawrence D., Jose J. Terz, Lister Hill, et al.. (1989). Evaluation of a short‐stay program for patients undergoing mastectomy. Journal of Surgical Oncology. 41(2). 98–102. 12 indexed citations

17.

López-Jamar, José Miguel Esteban, et al.. (1989). Effect of yttrium-90-labeled anti-carcinoembryonic antigen monoclonal antibody on the morphology and phenotype of human tumors grown as peritoneal carcinomatosis in athymic mice. Cancer. 63(7). 1343–1352. 14 indexed citations

18.

Chang, Alfred E., Yvedt L. Matory, Andrew J. Dwyer, et al.. (1987). Magnetic Resonance Imaging Versus Computed Tomography in the Evaluation of Soft Tissue Tumors of the Extremities. Annals of Surgery. 205(4). 340–348. 98 indexed citations

19.

Hyams, David M.. (1987). Therapy of Peritoneal Carcinomatosis of Human Colon Cancer Xenografts With Yttrium 90—Labeled Anti—Carcinoembryonic Antigen Antibody ZCE025. Archives of Surgery. 122(11). 1333–1333. 18 indexed citations

20.

Paling, Michael R. & David M. Hyams. (1982). Computed Tomography in Malignant Fibrous Histiocytoma. Journal of Computer Assisted Tomography. 6(4). 785–788. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact